156 related articles for article (PubMed ID: 37758451)
21. Management of trophoblastic tumors : review of evidence, current practice, and future directions.
Deleuze A; Massard C; Le Du F; You B; Lefeuvre-Plesse C; Bolze PA; de la Motte Rouge T
Expert Rev Anticancer Ther; 2023 Jul; 23(7):699-708. PubMed ID: 37198729
[TBL] [Abstract][Full Text] [Related]
22. Short tandem repeat analysis to identify the causative pregnancy of high-risk gestational trophoblastic neoplasia: Molar versus nonmolar pregnancy and its relation to the outcome.
Nishino K; Yamamoto E; Oda Y; Watanabe E; Niimi K; Yamamoto T; Kajiyama H
Placenta; 2021 Sep; 112():28-35. PubMed ID: 34247032
[TBL] [Abstract][Full Text] [Related]
23. [Preliminary study of PD-1 inhibitor in the treatment of drug-resistant recurrent gestational trophoblastic neoplasia].
Cheng HY; Yang JJ; Zhao J; Ren T; Feng FZ; Wan XR; Xiang Y
Zhonghua Fu Chan Ke Za Zhi; 2020 Jun; 55(6):390-394. PubMed ID: 32842245
[No Abstract] [Full Text] [Related]
24. [Clinical and radiological features of gestational trophoblastic tumors].
Mamouni N; Boumhaoued S; Erraghay S; Boubou M; Bouchikhi C; Banani A
Pan Afr Med J; 2017; 28():228. PubMed ID: 29629014
[TBL] [Abstract][Full Text] [Related]
25. Camrelizumab plus apatinib in patients with high-risk chemorefractory or relapsed gestational trophoblastic neoplasia (CAP 01): a single-arm, open-label, phase 2 trial.
Cheng H; Zong L; Kong Y; Wang X; Gu Y; Cang W; Zhao J; Wan X; Yang J; Xiang Y
Lancet Oncol; 2021 Nov; 22(11):1609-1617. PubMed ID: 34624252
[TBL] [Abstract][Full Text] [Related]
26. Stage IV Gestational Choriocarcinoma Diagnosed in the Third Trimester.
Jorgensen K; Roychowdhury M; da Cunha G; Kim YB; Schorge JO
Obstet Gynecol; 2019 Jan; 133(1):163-166. PubMed ID: 30531566
[TBL] [Abstract][Full Text] [Related]
27. Ultra-High-Risk Gestational Choriocarcinoma of the Ovary Associated with Ectopic Pregnancy.
Malovrh EP; Lukinovič N; Bujas T; Sobočan M; Knez J
Curr Oncol; 2023 Feb; 30(2):2217-2226. PubMed ID: 36826132
[TBL] [Abstract][Full Text] [Related]
28. Current chemotherapeutic options for the treatment of gestational trophoblastic disease.
Braga A; Paiva G; Cattai CJ; Elias KM; Horowitz NS; Berkowitz RS
Expert Opin Pharmacother; 2023 Feb; 24(2):245-258. PubMed ID: 36399723
[TBL] [Abstract][Full Text] [Related]
29. Gestational trophoblastic syndrome: an audit of 112 patients. A South African experience.
Moodley M; Tunkyi K; Moodley J
Int J Gynecol Cancer; 2003; 13(2):234-9. PubMed ID: 12657130
[TBL] [Abstract][Full Text] [Related]
30. Choriocarcinoma in Women: Analysis of a Case Series With Genotyping.
Savage J; Adams E; Veras E; Murphy KM; Ronnett BM
Am J Surg Pathol; 2017 Dec; 41(12):1593-1606. PubMed ID: 28877059
[TBL] [Abstract][Full Text] [Related]
31. [A clinicopathological study on gestational trophoblastic disease comparing with high risk criteria and diagnostic score of choriocarcinoma].
Matsui H; Kobayashi O; Eguchi O; Takamizawa H
Nihon Sanka Fujinka Gakkai Zasshi; 1990 Sep; 42(9):1224-8. PubMed ID: 2170547
[TBL] [Abstract][Full Text] [Related]
32. A Case Series of Five Patients With Pure or Mixed Gestational Epithelioid Trophoblastic Tumors and a Literature Review on Mixed Tumors.
Tse KY; Chiu KWH; Chan KKL; Chu MMY; Ngu SF; Cheung ANY; Ngan HYS; Ip PPC
Am J Clin Pathol; 2018 Aug; 150(4):318-332. PubMed ID: 29897391
[TBL] [Abstract][Full Text] [Related]
33. Metastatic choriocarcinoma to the pancreas.
Alvarez NR; Lambrou N; Solorzano CC
Am Surg; 2005 Apr; 71(4):330-2. PubMed ID: 15943408
[TBL] [Abstract][Full Text] [Related]
34. Durable remission for a woman with refractory choriocarcinoma treated with anti-endoglin monoclonal antibody and bevacizumab: A case from the New England Trophoblastic Disease Center, Brigham and Women's Hospital and Dana-Farber Cancer Institute.
Worley MJ; Elias KM; Horowitz NS; Quade BJ; Berkowitz RS
Gynecol Oncol; 2018 Jan; 148(1):5-11. PubMed ID: 29217138
[TBL] [Abstract][Full Text] [Related]
35. Relative Effects of Age, Race, and Stage on Mortality in Gestational Choriocarcinoma.
Tarney CM; Tian C; Craig ER; Crothers BA; Chan JK; Gist GD; Bateman NW; Conrads TP; Hamilton CA; Larry Maxwell G; Darcy KM
Int J Gynecol Cancer; 2018 Feb; 28(2):338-345. PubMed ID: 29232272
[TBL] [Abstract][Full Text] [Related]
36. Gestational trophoblastic neoplasia with brain metastasis at initial presentation: a retrospective study.
Gavanier D; Leport H; Massardier J; Abbas F; Schott AM; Hajri T; Golfier F; Bolze PA
Int J Clin Oncol; 2019 Feb; 24(2):153-160. PubMed ID: 30242539
[TBL] [Abstract][Full Text] [Related]
37. EP-EMA regimen (etoposide and cisplatin with etoposide, methotrexate, and dactinomycin) in a series of 18 women with gestational trophoblastic neoplasia.
Han SN; Amant F; Leunen K; Devi UK; Neven P; Vergote I
Int J Gynecol Cancer; 2012 Jun; 22(5):875-80. PubMed ID: 22635033
[TBL] [Abstract][Full Text] [Related]
38. Japanese trial for classification of gestational trophoblastic disease.
Sasaki S; Sasaki Y
J Reprod Med; 2008 Aug; 53(8):583-8. PubMed ID: 18773622
[TBL] [Abstract][Full Text] [Related]
39. Intraplacental choriocarcinoma: Systematic review and management guidance.
Jiao L; Ghorani E; Sebire NJ; Seckl MJ
Gynecol Oncol; 2016 Jun; 141(3):624-631. PubMed ID: 27020699
[TBL] [Abstract][Full Text] [Related]
40. Study and treatment of gestational trophoblastic diseases at the John I. Brewer Trophoblastic Disease Center, 1962-1990.
Lurain JR; Sciarra JJ
Eur J Gynaecol Oncol; 1991; 12(6):425-8. PubMed ID: 1667098
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
